Law360, New York (June 01, 2009) -- In a blow to both sides battling over conflicting patents related to the antidepressant citalopram, a federal judge found two claims of plaintiff Infosint SA's patent obvious but also invalidated the first claim of the patent belonging defendant H. Lundbeck A/S after finding the company had suppressed or concealed its invention.
Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York issued the mixed ruling Thursday that partially granted summary judgment to defendants Lundbeck and...
